news.modernatx.comNews and Blog Posts
news.modernatx.com Profile
News.modernatx.com is a subdomain of modernatx.com,
which was created on 2010-09-07,making it 13 years ago.
It has several subdomains, such as investors.modernatx.com
assets.modernatx.com , among others.
Description：Read and download all Moderna-related news related to Moderna's COVID-19 vaccine, boosters, internal updates, and more from the year 2012 through...
Discover news.modernatx.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
news.modernatx.com Information
| HomePage size: 114.764 KB |
| Page Load Time: 0.151588 Seconds |
| Website IP Address: 162.159.129.11 |
news.modernatx.com Similar Website
| Bibles for America Blog | Visit regularly to enjoy helpful posts on the Christian life and the Bible |
| Cottone Auctions Blog, Posts & News | Cottone Auctions |
| NASPO Pulse - Procurement Podcasts, Blog Posts and More |
| Poly Haven Blog – Irregular long-form blog. For the latest news, see the posts on Patreon. |
| Vinfolio Blog | Wine Posts - Industry News & Collector Resources |
| Archive of posts from Saba-News.com – Archive Saba News |
| Our blog posts - Coorganiz blog |
| Tendenci Blog | Posts on Tendenci - The Open Source AMS and MMS for Associations and Non-Profits |
| Latest news posts - News - Battlelog
/ Battlefield 4 |
| Blog posts And Articles - Faux Brushes |
| Blog Posts for Microsoft Dynamics 365 and Dynamics CRM | Magnetism Solutions | NZ (Auckland, |
| Nicholas Serra's dev blog – Posts about programming and |
| mentorworks-blog-posts - MentorWorks Education Finance and Coaching |
| EvolveWare News & Blog Posts - EvolveWare |
| Makeup Trending Posts and Articles | Makeup Blog | Kiro Beauty |
news.modernatx.com PopUrls
| Request Meeting Iframe https://news.modernatx.com/request-meeting-iframe/default.aspx |
| Melanie Ivarsson, Ph.D. Joins Moderna as Chief Development ... https://news.modernatx.com/news/news-details/2020/Melanie-Ivarsson-Ph.D.-Joins-Moderna-as-Chief-Development-Officer/default.aspx |
| Moderna Announces FDA Authorization of Third Dose of ... https://news.modernatx.com/news/news-details/2021/Moderna-Announces-FDA-Authorization-of-Third-Dose-of-COVID-19-Vaccine-for-Immunocompromised-Individu |
| Moderna Receives FDA Fast Track Designation for mRNA ... https://news.modernatx.com/news/news-details/2020/Moderna-Receives-FDA-Fast-Track-Designation-for-mRNA-Vaccine-mRNA-1273-Against-Novel-Coronavirus/def |
| Moderna Announces Phase 3 COVE Study of mRNA Vaccine ... https://news.modernatx.com/news/news-details/2020/Moderna-Announces-Phase-3-COVE-Study-of-mRNA-Vaccine-Against-COVID-19-mRNA-1273-Begins/default.aspx |
| Moderna Announces First Participants Dosed in Phase 2/3 ... https://news.modernatx.com/news/news-details/2020/Moderna-Announces-First-Participants-Dosed-in-Phase-23-Study-of-COVID-19-Vaccine-Candidate-in-Adoles |
| Moderna Completes Enrollment of Phase 2 Study of its mRNA ... https://news.modernatx.com/news/news-details/2020/Moderna-Completes-Enrollment-of-Phase-2-Study-of-its-mRNA-Vaccine-Against-COVID-19-mRNA-1273/default |
| Moderna Announces Submission of Initial Data to U.S. FDA for ... https://news.modernatx.com/news/news-details/2021/Moderna-Announces-Submission-of-Initial-Data-to-U.S.-FDA-for-Its-COVID-19-Vaccine-Booster/default.as |
| Moderna Appoints Melissa J. Moore, Ph.D., as Chief Scientific ... https://news.modernatx.com/news/news-details/2016/Moderna-Appoints-Melissa-J.-Moore-Ph.D.-as-Chief-Scientific-Officer-of-Modernas-mRNA-Research-Platfo |
| Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine https://news.modernatx.com/news/news-details/2023/Moderna-Receives-U.S.-FDA-Approval-for-Updated-COVID-19-Vaccine/default.aspx |
| Moderna Achieves Positive Interim Results from Phase 3 Trial of Next ... https://news.modernatx.com/news/news-details/2024/Moderna-Achieves-Positive-Interim-Results-from-Phase-3-Trial-of-Next-Generation-COVID-19-Vaccine/def |
| Moderna Clinical Trial Data Confirm Its Updated Covid-19 Vaccine ... https://news.modernatx.com/news/news-details/2023/Moderna-Clinical-Trial-Data-Confirm-Its-Updated-Covid-19-Vaccine-Generates-Strong-Immune-Response-in |
| Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials https://news.modernatx.com/news/news-details/2024/Moderna-Advances-Multiple-Vaccine-Programs-to-Late-Stage-Clinical-Trials/default.aspx |
| Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An ... https://news.modernatx.com/news/news-details/2023/Moderna-Granted-FDA-Breakthrough-Therapy-Designation-for-mRNA-1345-An-Investigational-Respiratory-Sy |
| Moderna Files for FDA Authorization of Its Updated COVID-19 Vaccine https://news.modernatx.com/news/news-details/2023/Moderna-Files-for-FDA-Authorization-of-Its-Updated-COVID-19-Vaccine/default.aspx |
news.modernatx.com Httpheader
| Date: Mon, 13 May 2024 09:22:12 GMT |
| Content-Type: text/html; charset=utf-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| CF-Ray: 8831952e69ff7bef-LAX |
| CF-Cache-Status: REVALIDATED |
| Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
| Strict-Transport-Security: max-age=31536000; includeSubDomains |
| Vary: Accept-Encoding |
| X-Content-Type-Options: nosniff |
| X-Frame-Options: SAMEORIGIN |
| X-XSS-Protection: 1; mode=block |
| Server: cloudflare |
news.modernatx.com Meta Info
| content="text/html; charset=utf-8" http-equiv="Content-type"/ |
| content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
| content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
| content="width=device-width, initial-scale=1" name="viewport"/ |
| content="default-src 'self' https: http: 'unsafe-inline' 'unsafe-eval' *.q4inc.com; img-src 'self' https: data: *.q4inc.com; script-src 'self' *.cloudfront.net *.contextweb.com *.pusherapp.com *.osano.com *.newrelic.com *.nr-data.net *.bugherd.com *.q4cdn.com *.s4.q4web.com *.q4web.com *.amazonaws.com *.highcharts.com *.googletagmanager.com *.googleadservices.com *.google-analytics.com *.google.com *.gstatic.com *.q4app.com *.pendo.io *.tiqcdn.com *.bing.com *.modernatx.com 'unsafe-inline' 'unsafe-eval' blob: *.q4inc.com" http-equiv="Content-Security-Policy"/ |
| content="dhn27iPA0JVcFHfVyY9c4Rd6vrMZy0eiaZCfFyX7tk4" name="google-site-verification"/ |
| content="7PZC33CdqIbp0gWcZwGxHNtjuQpXcOTuQqGcQxSCY3k" name="google-site-verification"/ |
| content="GVZS7zz7KJgBEsQzGOyD-U-WEgNTz-1VG7J3-BKOa1A" name="google-site-verification"/ |
| content="Read and download all Moderna-related news related to Moderna's COVID-19 vaccine, boosters, internal updates, and more from the year 2012 through 2022" name="description"/ |
news.modernatx.com Html To Plain Text
The Power of mRNA Research Responsibility COVID-19 Overview News Events & Presentations Events & Presentations Investor Days Scientific & Medical Meetings Development Programs Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator Analyst Coverage Financials Quarterly Results Annual Reports SEC Filings Governance Governance Documents Leadership Team Committee Composition Resources Investor FAQs Information Request Form Investor Email Alerts Investor Contacts Statements & Perspectives Overview News Events & Presentations Events & Presentations Investor Days Scientific & Medical Meetings Development Programs Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator Analyst Coverage Financials Quarterly Results Annual Reports SEC Filings Governance Governance Documents Leadership Team Committee Composition Resources Investor FAQs Information Request Form Investor Email Alerts Investor Contacts Statements & Perspectives Overview News Events & Presentations Events & Presentations Investor Days Scientific & Medical Meetings Development Programs Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator Analyst Coverage Financials Quarterly Results Annual Reports SEC Filings Governance Governance Documents Leadership Team Committee Composition Resources Investor FAQs Information Request Form Investor Email Alerts Investor Contacts Statements & Perspectives Selecting a year value will change the news content Select Year: Loading Selecting a category value will change the news content Select Category: All Blog Quick Links SEC Filings Investor FAQs Information Request Form IR Contact [email protected] Investor Email Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Moderna, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Moderna to send you the requested Investor Email Alert updates. * Required Email Address * Investor Alert Options Investor Alert Options * News Events & Presentations Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote Unsubscribe Email Alert Sign Up Confirmation Investors Investor overview Newsroom Press releases Media kit Media Center All Media Blogs Partnerships Strategic collaborators Careers Company culture People behind the science Join our team Innovation Incubator New venture labs Instagram Twitter Facebook LinkedIn Terms of Use Site Map Privacy Policy Contact Moderna © Moderna,...
news.modernatx.com Whois
Domain Name: MODERNATX.COM Registry Domain ID: 1614668183_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2022-09-26T22:19:10Z Creation Date: 2010-09-07T15:34:50Z Registry Expiry Date: 2027-09-07T15:34:50Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2086851750 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1121.AWSDNS-12.ORG Name Server: NS-1766.AWSDNS-28.CO.UK Name Server: NS-355.AWSDNS-44.COM Name Server: NS-877.AWSDNS-45.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T16:42:23Z <<<